Abstract:Background To explore the correlation between gut microbiota and disease severity in patients with primary biliary cholangitis (PBC). Methods According to the natural course of the disease, 18 PBC patients were divided into two groups: early stage (asymptomatic stage and symptomatic stage) and decompensated stage. Ten patients with decompensated hepatitis B cirrhosis, 10 patients with decompensated alcoholic cirrhosis, and 10 healthy people were selected as controls. 16sRNA sequencing was performed in the fresh feces of the research subjects. To compare the composition of gut microbiota among decompensated PBC and early-stage PBC as well as other common decompensated chronic liver disease patients. Correlation analysis was conducted with clinical indicators. Results The diversity and abundance of gut microbiota in PBC patients decreased significantly compared to the healthy control group. The composition of the gut microbiota in the early PBC group was similar to that of the healthy control group, while the composition of the gut microbiota in the decompensated PBC group was less similar to that of the healthy control group (figure 1). Upon correlating clinical indicators with gut microbiota, it was revealed that genera such as Roseburia, Agathobacter, and Ruminococcus were found to be negatively correlated with the Child-Pugh score and total bilirubin (TBIL) levels, while positively correlated with albumin levels (figure 2). Furthermore, employing LEfSe for all groups comparisons, a total of 8 potential biomarkers at the genus level were identified: Agathobacter and Fusicatenibacter in the healthy control; Ligilactobacillus and Roseburia in the early PBC group; Veillonella and Klebsiella in the decompensated PBC group; Dialister in the decompensated hepatitis B cirrhosis group; Faecalibacterium in the decompensated alcoholic cirrhosis group (figure 3). Conclusions The gut microbiota of PBC patients exhibit dysbiosis, suggesting its involvement in the pathogenesis of the disease. Gut microbiota may potentially distinguish PBC from other common decompensated chronic liver diseases. Certain specific gut microbiota may be associated with disease progression.

Retrospective study and meta-analysis:the clinical features of patients with primary biliary cirrhosis in recent 20 years in China

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

Retrospective analysis of clinical characteristics and curative effect of 26 patients with primary biliary cirrhosis

Clinical Characteristics of Primary Biliary Cirrhosis: a Retrospective Analysis of 101 Cases

Evidence for the Association Between IgG‐antimitochondrial Antibody and Biochemical Response to Ursodeoxycholic Acid Treatment in Primary Biliary Cholangitis

[Clinical Analysis of Primary Biliary Cirrhosis: a Report of 42 Cases].

Clinical characteristics of patients with primary biliary cirrhosis

Clinical Analysis of Primary Biliary Cirrbosis:A Report of 26 Cases

IDDF2022-ABS-0112 Clinical Features in Primary Biliary Cholangitis: a Retrospective Analysis of 52 Cases

Primary biliary cirrhosis:an analysis of 76 cases

Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials.

Scientific Publications on Primary Biliary Cirrhosis from 2000 Through 2010: an 11-Year Survey of the Literature

Clinical and laboratory examination characteristics in patients with primary biliary cirrhosis

Laboratory analysis of 361 PBC patients with AMA-M2 positive

Clinical Study of 25 Primary Biliary Cirrhosis Cases

[Clinical and Pathological Characteristics of Primary Biliary Cirrhosis].

Observation on Therapeutic Efficacy of Ursodeoxycholic Acid in Chinese Patients with Primary Biliary Cirrhosis: a 2-Year Follow-Up Study

Clinical and Pathology Analysis of Patients with Primary Biliary Cirrhosis

IDDF2024-ABS-0186 Analysis of the Correlation Between Gut Microbiota and Disease Severity in Patients with Primary Biliary Cholangitis

Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine A protocol for systematic review and meta analysis

[Clinical and Pathological Features of Primary Biliary Cirrhotic Patients with Negative Anti-Mitochondria Antibody].